Saving Pennies 4 A Cure is, 501(c)(3) nonprofit organization, dedicated to improving the lives of breast cancer patients by providing custom care packages for those undergoing chemotherapy. These packages provide helpful information on the adverse effects that accompany this treatment, easeing patient anxieties. We also provide resources that emphasize the importance of self-care and self advovacy. Our goals are to educate, advocate, public awareness and give back to the Cancer community.
Trials of Color
We advocate for diversity in clinical trials.
Did you know that only 5% of minorities are included in clinical trials?
Yet, the human body differs across races. For example, breast tissue was found to be different in Black women in comparison to White women. Trials of Color, a sister organization, was created to ensure diversity in clinical trials and broaden the research needed to find a cure for ALL people.
"Great things are done by a series of small things brought together."
Vincent Van Gogh
WE ARE STRONGER TOGETHER. WITH ACCESS TO OUR RESOURCES, WE ENVISION A FUTURE WHERE BREAST CANCER PATIENTS AND SURVIVORS WILL BE BETTER PREPARED AND EMOTIONALLY EMPOWERED THROUGHOUT THEIR RECOVERY JOURNEY
The founder, Sharon Rivera, is a triple-negative breast cancer survivor who turned her fight into a burning desire to empower other breast cancer patients. Triple-negative breast cancer (TNBC) is a rare form of breast cancer where the tumor does not have any of the three most common receptors that fuel breast cancer growth. This makes TNBC difficult to treat since the tumor can't be directly targeted. Sharon Rivera took part in a clinical trials studies with the Pink Lotus Foundation and University of PENN, Abramson Cancer Center to detect recurrences sooner for other breast cancer patients.
When they told me it was Triple Negative, I thought that was good thing. I was excited. I thought,
"I'm negative, that's great."
Many people have never heard of triple-negative breast cancer (TNBC), and I was one of them until I was diagnosed with it. As mentioned before, TNBC is a difficult-to-treat form of breast cancer since it does not have any of the three common receptor sites. When they told me it was Triple Negative, I thought that was a good thing. I was excited. I thought "I'm negative. That's great." And the surgeon shook his head and said "No, that's not good." I was diagnosed after a routine mammogram in 2015. I never missed my annual appointment and had no family history of breast cancer. TNBC is known to be aggressive, which I learned early on. When I was initially diagnosed, my lump measured one centimeter. Five weeks later, it was two centimeters. So already, within a five-week span, the tumor had grown. I underwent surgery and completed my chemo and radiation Later that year, but it took a toll on my body. I definitely had days where I didn't want to fight. My fight is far from over. TNBC has the highest recurrence and lowest survival rates of all the breast cancer subtypes, according to the Pink Lotus Foundation.